Peer Exchange Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.
All Peer Exchange Understanding the Comorbidities: Psoriasis and Metabolic Syndrome Managing Challenges of Insomnia in Elderly Patients The Challenges and Treatment of Sickle Cell Disease Identifying Secondary Progressive Multiple Sclerosis A Review of the Treatment for Multiple Myeloma Rare Neurological Diseases: Spinal Muscular Atrophy and Huntington's Disease An Introduction of a New Class for the Treatment of Bone Health An Overview of the Value-Based Marketplace The Progression of Type 2 Diabetes and the Treatment Options to Manage It Immunotherapy in the Oncology Care Model Preventive Treatments for Migraines The Use of Biologics for the Treatment of Asthma Improved Outcomes in the Management of Hepatic Encephalopathy Expert Perspectives on Schizophrenia Treatment Approaches and Relapse Prevention Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer Oncology Stakeholders Summit, Summer 2018 Emerging Treatment for Migraine Advances in the Treatment of Hyperhidrosis Special Considerations in HIV Management Finding Value in Today's New Insulin Technology in Diabetes Care: From Prevention to Disease Management
Age-Related Macular Degeneration Treatments: Determining Appropriate Use Diabetes Therapy and Cardiovascular Outcomes: An Update Oncology Stakeholders Summit, Spring 2017 Reducing CVD Risk Through Optimal Lipid Management Oncology Stakeholders Summit, Fall 2016 Management Optimization in Atopic Dermatitis Oral Oncolytics: Exploring Challenges in Cost, Adherence, and Management Reducing Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus Oncology Stakeholders Summit, Spring 2016 Diabetes-Related Complications: A Focus on Diabetic Macular Edema Oncology Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit 2014 Diabetes and Obesity Management Prostate Cancer Rare Disease Neurological Disorders Immunotherapy Diabetes and Cardiometabolic Health
October 18, 2019 –
Following perspective on cladribine in multiple sclerosis, panelists provide insight on selection and use amid disease-modifying therapy.
October 18, 2019 –
Experts home in on the benefit of siponimod, a sphingosine 1-phosphate receptor modulator, in managing multiple sclerosis.
October 17, 2019 –
Sundar Jagannath, MD, shares his approach to choosing the best treatment plan for patients based on genetic risk in multiple myeloma.
October 17, 2019 –
The key opinion leaders discuss the need for transparency between the National Comprehensive Cancer Network (NCCN) guidelines, payer preference, and real-world patient needs in multiple myeloma.
October 16, 2019 –
The panelists consider remaining challenges in sickle cell disease as they relate to the payer’s role.
October 16, 2019 –
A comprehensive discussion on sickle cell disease complication management that addresses disease severity and quality of life.
October 15, 2019 –
Key opinion leaders consider the economic and social burden of insomnia in elderly patients.
October 14, 2019 –
Peter L. Salgo, MD, leads a discussion on the identification of insomnia and its subtypes, delving into how physicians can effectively differentiate from chronic versus acute, primary versus secondary, and comorbid settings.
October 11, 2019 –
A panel of experts considers the role of ocrelizumab, an anti-CD20 monoclonal antibody, in treating multiple sclerosis.
October 11, 2019 –
Focusing on the management of multiple sclerosis, the panel outlines available nonpharmacologic and pharmacologic strategies.
